scholarly journals Parental Preferences for the Organization of Preschool Vaccination Programs Including Financial Incentives: A Discrete Choice Experiment

2017 ◽  
Vol 2 (1) ◽  
pp. 238146831770831
Author(s):  
Darren Flynn ◽  
Laura Ternent ◽  
Frauke Becker ◽  
Yemi Oluboyede ◽  
Jean Adams
PLoS ONE ◽  
2021 ◽  
Vol 16 (11) ◽  
pp. e0258945
Author(s):  
Jemima A. Frimpong ◽  
Stéphane Helleringer

Exposure notification apps have been developed to assist in notifying individuals of recent exposures to SARS-CoV-2. However, in several countries, such apps have had limited uptake. We assessed whether strategies to increase downloads of exposure notification apps should emphasize improving the accuracy of the apps in recording contacts and exposures, strengthening privacy protections and/or offering financial incentives to potential users. In a discrete choice experiment with potential app users in the US, financial incentives were more than twice as important in decision-making about app downloads, than privacy protections, and app accuracy. The probability that a potential user would download an exposure notification app increased by 40% when offered a $100 reward to download (relative to a reference scenario in which the app is free). Financial incentives might help exposure notification apps reach uptake levels that improve the effectiveness of contact tracing programs and ultimately enhance efforts to control SARS-CoV-2. Rapid, pragmatic trials of financial incentives for app downloads in real-life settings are warranted.


Vaccine ◽  
2014 ◽  
Vol 32 (47) ◽  
pp. 6277-6283 ◽  
Author(s):  
Jorien Veldwijk ◽  
Mattijs S. Lambooij ◽  
Patricia C.J. Bruijning-Verhagen ◽  
Henriette A. Smit ◽  
G. Ardine de Wit

2013 ◽  
Vol 16 (7) ◽  
pp. A362
Author(s):  
J. Veldwijk ◽  
M.S. Lambooij ◽  
P.C.J. Bruijning-Verhagen ◽  
H.A. Smit ◽  
G.A. de Wit

Vaccine ◽  
2020 ◽  
Vol 38 (52) ◽  
pp. 8310-8317
Author(s):  
Shan Zhu ◽  
Jie Chang ◽  
Khezar Hayat ◽  
Pengchao Li ◽  
Wenjing Ji ◽  
...  

2017 ◽  
Vol 20 (2) ◽  
pp. 181-189 ◽  
Author(s):  
Megan A Lewis ◽  
Alex Stine ◽  
Ryan S Paquin ◽  
Carol Mansfield ◽  
Dallas Wood ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. e0157403 ◽  
Author(s):  
Emma L. Giles ◽  
Frauke Becker ◽  
Laura Ternent ◽  
Falko F. Sniehotta ◽  
Elaine McColl ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Dana Alkhoury ◽  
Jared Atchison ◽  
Antonio J. Trujillo ◽  
Kimberly Oslin ◽  
Katherine P. Frey ◽  
...  

Abstract Background Smoking increases the risk of complications and related costs after an orthopaedic fracture. Research in other populations suggests that a one-time payment may incentivize smoking cessation. However, little is known on fracture patients’ willingness to accept financial incentives to stop smoking; and the level of incentive required to motivate smoking cessation in this population. This study aimed to estimate the financial threshold required to motivate fracture patients to stop smoking after injury. Methods This cross-sectional study utilized a discrete choice experiment (DCE) to elicit patient preferences towards financial incentives and reduced complications associated with smoking cessation. We presented participants with 12 hypothetical options with several attributes with varying levels. The respondents’ data was used to determine the utility of each attribute level and the relative importance associated with each attribute. Results Of the 130 enrolled patients, 79% reported an interest in quitting smoking. We estimated the financial incentive to be of greater relative importance (ri) (45%) than any of the included clinical benefits of smoking cessations (deep infection (ri: 24%), bone healing complications (ri: 19%), and superficial infections (ri: 12%)). A one-time payment of $800 provided the greatest utility to the respondents (0.64, 95% CI: 0.36 to 0.93), surpassing the utility associated with a single $1000 financial incentive (0.36, 95% CI: 0.18 to 0.55). Conclusions Financial incentives may be an effective tool to promote smoking cessation in the orthopaedic trauma population. The findings of this study define optimal payment thresholds for smoking cessation programs.


BMJ Open ◽  
2017 ◽  
Vol 7 (10) ◽  
pp. e016229 ◽  
Author(s):  
Joachim Marti ◽  
Marcus Bachhuber ◽  
Jordyn Feingold ◽  
David Meads ◽  
Michael Richards ◽  
...  

ObjectivesInvestigate the acceptability of financial incentives for initiating a medically supervised benzodiazepine discontinuation programme among people with long-term benzodiazepine use and to identify programme features that influence willingness to participate.MethodsWe conducted a discrete choice experiment in which we presented a variety of incentive-based programs to a sample of older adults with long-term benzodiazepine use identified using the outpatient electronic health record of a university-owned health system. We studied four programme variables: incentive amount for initiating the programme, incentive amount for successful benzodiazepine discontinuation, lottery versus certain payment and whether partial payment was given for dose reduction. Respondents reported their willingness to participate in the programmes and additional information was collected on demographics, history of use and anxiety symptoms.ResultsThe overall response rate was 28.4%. Among the 126 respondents, all four programme variables influenced stated preferences. Respondents strongly preferred guaranteed cash-based incentives as opposed to a lottery, and the dollar amount of both the starting and conditional incentives had a substantial impact on choice. Willingness to participate increased with the amount of conditional incentive. Programme participation also varied by gender, duration of use and income.ConclusionsParticipation in an incentive-based benzodiazepine discontinuation programme might be relatively low, but is modifiable by programme variables including incentive amounts. These results will be helpful to inform the design of future trials of benzodiazepine discontinuation programmes. Further research is needed to assess the financial viability and potential cost-effectiveness of such economic incentives.


Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 143-OR
Author(s):  
DAVENE WRIGHT ◽  
KRISTEN CHALMERS ◽  
JESSICA L. LEBLANC ◽  
JOYCE YI-FRAZIER ◽  
SEEMA K. SHAH ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document